BMRA — BIOMERICA INC
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 73290 ·
Last close
$2.47
Market Cap
$7.63M
52W High
$2.49
52W Low
$1.87
ADV30
18,049
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Feb 2026 | 987,000 | -44,000 | -1,298,000 | -1,312,000 | 4,878,000 | 1,336,000 | 1,561,000 |
| Nov 2025 | 1,210,000 | 51,000 | -1,373,000 | -1,320,000 | 6,034,000 | 2,543,000 | 1,599,000 |
| Aug 2025 | 1,380,000 | 424,000 | -1,118,000 | 2,000 | 6,854,000 | 3,053,000 | 1,699,000 |
| May 2025 | 749,000 | -244,000 | -1,564,000 | -1,544,000 | 5,945,000 | 2,399,000 | 1,840,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,170,000
Investing CF
$-56,000
Financing CF
$1,458,000
CapEx
$-4,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.37
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-55,798,000
Inventory
$1,645,000
Receivables
$941,000
ST Investments
—
EBIT TTM
$-5,353,000
Pretax Income TTM
$-4,153,000
Interest Exp TTM
$6,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,327,000
EBITDA
$-5,268,000
Free Cash Flow
$-2,028,375
Enterprise Value
$6,551,770
Total Cash
$1,336,000
Total Debt
$193,000
Shares Out
3,090,269
Trailing EPS
$-1.63
Book Value
$1.09
ROE
-94.3%
ROA
-54.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| May 2025 | 5,311,000 | -5,137,000 | -4,973,000 | 5,945,000 | 1,840,000 | — | -3,841,000 |
| May 2024 | 5,415,000 | -6,367,000 | -5,978,000 | 9,254,000 | 2,663,000 | — | -5,361,000 |
| May 2023 | 5,339,000 | -7,223,000 | -7,140,000 | 14,454,000 | 2,730,000 | — | -5,474,000 |
| May 2022 | 18,871,000 | -4,534,000 | -4,531,000 | 11,374,000 | 3,049,000 | — | -479,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.39
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BIAF | bioAffinity Technologies, Inc. | $7.48M | $1.65 | — |
| NOTV | Inotiv, Inc. | $9.30M | $0.27 | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.24M | $1.77 | — |
| BUDZ | WEED, INC. | $5.04M | $0.03 | — |
| ISPC | iSpecimen Inc. | $4.86M | $3.38 | — |
News headlines (Yahoo Finance, 1h cache)
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
2026-04-29 12:19 · Yahoo
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway
2026-04-16 12:19 · Yahoo
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
2026-04-14 12:19 · Yahoo
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
2026-04-13 22:57 · Yahoo
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe
2026-03-18 12:19 · Yahoo
Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain
2026-03-05 13:19 · Yahoo
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
2026-02-26 13:19 · Yahoo
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
2026-02-18 13:19 · Yahoo
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
2026-01-14 22:17 · Yahoo
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
2025-12-23 13:19 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.